The mission of the Belgian Inflammatory Bowel Disease Research and Development Group (BIRD) is to stimulate research in the field of Inflammatory Bowel disease (IBD).
The BIRD group furthermore wants to improve clinical and scientific knowledge about the disease between gastroenterologists. By performing original epidemiological and clinical studies, we want to be at the forefront of improving existing therapies, and providing the best care to IBD patients. We want to advance the current understanding on the pathogenesis of the disease and we have a strong commitment to support young clinicians and/or researchers through scientific grants.
We invite you to have a closer look at our website!!
COVID-19: Informations pour les patients MICI
Corona_version française (update 28 avril 2021)
Cher patient MICI,
Compte tenu des nombreuses questions qui se posent sur l'épidémie de et la vaccination contre couronne, vous pouvez cliquer sur MORE --> pour trouver des informations générales.
Ces informations sont ajustées à mesure que de nouveaux développements se produisent.
COVID-19: Informatie voor IBD patiënten
Corona_Nederlandstalige versie (update 28 April 2021)
Beste IBD patiënt,
Gezien de vele vragen die er rijzen naar aanleiding van de corona epidemie en de vaccinatie, kan u hier doorklikken op
MORE--> om algemene informatie terug te vinden.
Deze informatie wordt aangepast naarmate zich nieuwe ontwikkelingen voordoen.
Scientific papers
Large Sample Size, Wide Variant Spectrum, and Advanced Machine-Learning Technique Boost Risk Prediction for Inflammatory Bowel Disease
The American Journal of Human Genetics 92, 1008-1012, June 6, 2013
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Nature genetics, MARCH 2011, VOLUME 43, NUMBER 3
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Nature Genetics, AUGUST 2008, VOLUME 40, NUMBER 8